Process View
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "male gonad development"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| FGFR2 | fibroblast growth factor receptor 2 | 0.981 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.769 | ||
| AKR1C2 | aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III) | 0.760 | Human | |
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.758 | ||
| LAT | linker for activation of T cells | 0.692 | ||
| AKR1C1 | aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase) | 0.582 | Human | |
| FGF1 | fibroblast growth factor 1 (acidic) | 0.529 | Human | |
| MPDZ | multiple PDZ domain protein | 0.421 | ||
| PDX1 | pancreatic and duodenal homeobox 1 | 0.363 | ||
| NCOA3 | nuclear receptor coactivator 3 | 0.357 | ||
| TRIP6 | thyroid hormone receptor interactor 6 | 0.353 | ||
| ESR1 | estrogen receptor 1 | 0.342 | Mouse Rat | |
| PAX3 | paired box 3 | 0.326 | ||
| AR | androgen receptor | 0.306 | Mouse | |
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.282 | ||
| FGF10 | fibroblast growth factor 10 | 0.274 | Human | |
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.241 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.237 | Mouse | |
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.211 | ||
| KCNE1 | potassium voltage-gated channel, Isk-related family, member 1 | 0.210 | ||
| CREBBP | CREB binding protein | 0.200 | ||
| ARID4A | AT rich interactive domain 4A (RBP1-like) | 0.192 | Mouse | |
| EGR1 | early growth response 1 | 0.176 | Human | |
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.166 | ||
| AKR1C3 | aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) | 0.164 | ||
| ARID4B | AT rich interactive domain 4B (RBP1-like) | 0.151 | Mouse | |
| EGR3 | early growth response 3 | 0.145 | Human | |
| GATA4 | GATA binding protein 4 | 0.141 | ||
| TOP2A | topoisomerase (DNA) II alpha 170kDa | 0.133 | ||
| NGF | nerve growth factor (beta polypeptide) | 0.132 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.124 | ||
| GFI1B | growth factor independent 1B transcription repressor | 0.120 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.118 | ||
| POU5F1 | POU class 5 homeobox 1 | 0.113 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.112 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.111 | Human | |
| FANCD2 | Fanconi anemia, complementation group D2 | 0.110 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.107 | ||
| BCL2L1 | BCL2-like 1 | 0.106 | Mouse | |
| AP1M1 | adaptor-related protein complex 1, mu 1 subunit | 0.106 | ||
| BAD | BCL2-associated agonist of cell death | 0.104 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.101 | ||
| NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.096 | ||
| BRCA1 | breast cancer 1, early onset | 0.094 | ||
| NR5A1 | nuclear receptor subfamily 5, group A, member 1 | 0.091 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.090 | ||
| RORA | RAR-related orphan receptor A | 0.088 | ||
| FZD1 | frizzled homolog 1 (Drosophila) | 0.085 | ||
| SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.082 | ||
| RAD50 | RAD50 homolog (S. cerevisiae) | 0.082 | ||
| PAX8 | paired box 8 | 0.081 | ||
| EGR2 | early growth response 2 | 0.077 | Human | |
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.077 | ||
| HDAC1 | histone deacetylase 1 | 0.072 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.072 | ||
| TFAP2C | transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) | 0.063 | ||
| FANCE | Fanconi anemia, complementation group E | 0.061 | ||
| UBR5 | ubiquitin protein ligase E3 component n-recognin 5 | 0.060 | ||
| CHEK2 | CHK2 checkpoint homolog (S. pombe) | 0.060 | ||
| MSH6 | mutS homolog 6 (E. coli) | 0.060 | ||
| PGF | placental growth factor | 0.059 | ||
| WNT1 | wingless-type MMTV integration site family, member 1 | 0.059 | Human | |
| TBX5 | T-box 5 | 0.058 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.057 | ||
| FANCB | Fanconi anemia, complementation group B | 0.057 | ||
| RET | ret proto-oncogene | 0.057 | ||
| FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.054 | ||
| MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.053 | ||
| SOX2 | SRY (sex determining region Y)-box 2 | 0.053 | Human | |
| PROX1 | prospero homeobox 1 | 0.051 | ||
| RNR2 | l-rRNA | 0.051 | ||
| HDAC2 | histone deacetylase 2 | 0.051 | ||
| FOXC2 | forkhead box C2 (MFH-1, mesenchyme forkhead 1) | 0.050 | ||
| NEUROD1 | neurogenic differentiation 1 | 0.050 | ||
| MRE11A | MRE11 meiotic recombination 11 homolog A (S. cerevisiae) | 0.050 | ||
| UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.047 | ||
| KITLG | KIT ligand | 0.046 | ||
| ZNF292 | zinc finger protein 292 | 0.044 | ||
| BAX | BCL2-associated X protein | 0.044 | Mouse | |
| SH3BP4 | SH3-domain binding protein 4 | 0.043 | ||
| SF3A2 | splicing factor 3a, subunit 2, 66kDa | 0.042 | ||
| FGF4 | fibroblast growth factor 4 | 0.042 | Human | |
| FGF18 | fibroblast growth factor 18 | 0.041 | ||
| SMAD4 | SMAD family member 4 | 0.041 | ||
| SFRP5 | secreted frizzled-related protein 5 | 0.041 | ||
| DDX17 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 17 | 0.040 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.039 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.039 | ||
| PTPN13 | protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) | 0.038 | ||
| ACP5 | acid phosphatase 5, tartrate resistant | 0.038 | ||
| MEOX2 | mesenchyme homeobox 2 | 0.037 | ||
| GDNF | glial cell derived neurotrophic factor | 0.036 | Rat | |
| FGF7 | fibroblast growth factor 7 | 0.036 | Human | |
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.036 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.036 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.035 | ||
| LBX1 | ladybird homeobox 1 | 0.034 | ||
| NRP1 | neuropilin 1 | 0.034 | ||
| SMAD1 | SMAD family member 1 | 0.033 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.032 | ||
| HBP1 | HMG-box transcription factor 1 | 0.032 | ||
| EGFR | epidermal growth factor receptor | 0.032 | ||
| FOXD3 | forkhead box D3 | 0.031 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.031 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.031 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.030 | ||
| FANCC | Fanconi anemia, complementation group C | 0.030 | ||
| MGEA5 | meningioma expressed antigen 5 (hyaluronidase) | 0.028 | ||
| CALCA | calcitonin-related polypeptide alpha | 0.027 | ||
| SF3B4 | splicing factor 3b, subunit 4, 49kDa | 0.027 | ||
| HOXB5 | homeobox B5 | 0.026 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.026 | ||
| HOXA10 | homeobox A10 | 0.026 | ||
| CAT | catalase | 0.026 | ||
| TBX1 | T-box 1 | 0.026 | ||
| GATA5 | GATA binding protein 5 | 0.026 | Human | |
| MYST2 | MYST histone acetyltransferase 2 | 0.025 | ||
| FOXC1 | forkhead box C1 | 0.025 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.025 | ||
| INHBB | inhibin, beta B | 0.025 | Human | |
| PAX7 | paired box 7 | 0.024 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.024 | Mouse | |
| RNF144B | ring finger protein 144B | 0.024 | ||
| FGF2 | fibroblast growth factor 2 (basic) | 0.023 | Human | |
| DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 0.023 | ||
| VEGFA | vascular endothelial growth factor A | 0.023 | ||
| CDX2 | caudal type homeobox 2 | 0.023 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.023 | ||
| HOXB13 | homeobox B13 | 0.023 | ||
| EIF4G2 | eukaryotic translation initiation factor 4 gamma, 2 | 0.022 | ||
| TBX2 | T-box 2 | 0.022 | ||
| KDM5B | lysine (K)-specific demethylase 5B | 0.022 | ||
| DHH | desert hedgehog | 0.022 | ||
| FGF3 | fibroblast growth factor 3 | 0.022 | Human | |
| INHA | inhibin, alpha | 0.022 | Rat | |
| SMAD7 | SMAD family member 7 | 0.022 | ||
| HOXD1 | homeobox D1 | 0.022 | ||
| SMAD2 | SMAD family member 2 | 0.022 | ||
| PGR | progesterone receptor | 0.021 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.021 | Fly | |
| FOXA2 | forkhead box A2 | 0.021 | ||
| AQP5 | aquaporin 5 | 0.021 | ||
| PAX2 | paired box 2 | 0.021 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.021 | ||
| POU3F2 | POU class 3 homeobox 2 | 0.021 | ||
| ESRRG | estrogen-related receptor gamma | 0.021 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.020 | ||
| TP53BP2 | tumor protein p53 binding protein, 2 | 0.020 | ||
| NR0B1 | nuclear receptor subfamily 0, group B, member 1 | 0.020 | ||
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.020 | ||
| SLC6A2 | solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 | 0.020 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.020 | ||
| CLASP2 | cytoplasmic linker associated protein 2 | 0.019 | ||
| HOXD12 | homeobox D12 | 0.019 | Fly | |
| HMGA2 | high mobility group AT-hook 2 | 0.019 | ||
| LDLR | low density lipoprotein receptor | 0.019 | ||
| SIM2 | single-minded homolog 2 (Drosophila) | 0.019 | ||
| BARX1 | BARX homeobox 1 | 0.019 | ||
| LRP6 | low density lipoprotein receptor-related protein 6 | 0.018 | ||
| CALCR | calcitonin receptor | 0.018 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.018 | Human | |
| SIX6 | SIX homeobox 6 | 0.018 | ||
| HOXD13 | homeobox D13 | 0.018 | ||
| HNRNPUL1 | heterogeneous nuclear ribonucleoprotein U-like 1 | 0.018 | ||
| FOXE1 | forkhead box E1 (thyroid transcription factor 2) | 0.018 | ||
| DMRT1 | doublesex and mab-3 related transcription factor 1 | 0.018 | ||
| RXRA | retinoid X receptor, alpha | 0.018 | ||
| BCL2L2 | BCL2-like 2 | 0.018 | ||
| OTP | orthopedia homeobox | 0.018 | ||
| RAD23B | RAD23 homolog B (S. cerevisiae) | 0.017 | ||
| BHLHE23 | basic helix-loop-helix family, member e23 | 0.017 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.017 | ||
| MYOD1 | myogenic differentiation 1 | 0.017 | ||
| FOXA1 | forkhead box A1 | 0.017 | ||
| HOXD9 | homeobox D9 | 0.017 | ||
| SALL2 | sal-like 2 (Drosophila) | 0.017 | Fly | |
| HAND2 | heart and neural crest derivatives expressed 2 | 0.017 | ||
| MMP11 | matrix metallopeptidase 11 (stromelysin 3) | 0.017 | ||
| MSH3 | mutS homolog 3 (E. coli) | 0.017 | ||
| FOXF1 | forkhead box F1 | 0.017 | ||
| FST | follistatin | 0.017 | ||
| ATM | ataxia telangiectasia mutated | 0.016 | ||
| FRS2 | fibroblast growth factor receptor substrate 2 | 0.016 | ||
| HES2 | hairy and enhancer of split 2 (Drosophila) | 0.016 | ||
| ID4 | inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | 0.016 | ||
| AMHR2 | anti-Mullerian hormone receptor, type II | 0.016 | ||
| RANBP9 | RAN binding protein 9 | 0.016 | ||
| NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.016 | Human | |
| TTR | transthyretin | 0.015 | ||
| BIK | BCL2-interacting killer (apoptosis-inducing) | 0.015 | ||
| CYP26A1 | cytochrome P450, family 26, subfamily A, polypeptide 1 | 0.015 | ||
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.015 | ||
| PIK3CA | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 0.015 | ||
| NGFR | nerve growth factor receptor | 0.015 | ||
| SOX9 | SRY (sex determining region Y)-box 9 | 0.015 | ||
| SOX11 | SRY (sex determining region Y)-box 11 | 0.015 | Human | |
| NKX2-1 | NK2 homeobox 1 | 0.015 | Mouse | |
| ERG | v-ets erythroblastosis virus E26 oncogene homolog (avian) | 0.015 | ||
| MED25 | mediator complex subunit 25 | 0.015 | ||
| PHF3 | PHD finger protein 3 | 0.015 | ||
| TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.015 | ||
| FOXN4 | forkhead box N4 | 0.015 | ||
| CDKN2C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | 0.014 | ||
| HMX1 | H6 family homeobox 1 | 0.014 | ||
| SOX1 | SRY (sex determining region Y)-box 1 | 0.014 | Human | |
| HRK | harakiri, BCL2 interacting protein (contains only BH3 domain) | 0.014 | ||
| IDH1 | isocitrate dehydrogenase 1 (NADP+), soluble | 0.014 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.014 | ||
| TLX2 | T-cell leukemia homeobox 2 | 0.014 | ||
| POU2F3 | POU class 2 homeobox 3 | 0.014 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.014 | ||
| PTPN4 | protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte) | 0.014 | ||
| MED1 | mediator complex subunit 1 | 0.014 | ||
| SPDEF | SAM pointed domain containing ets transcription factor | 0.014 | ||
| FZD7 | frizzled homolog 7 (Drosophila) | 0.014 | ||
| HIC1 | hypermethylated in cancer 1 | 0.014 | ||
| NEUROG3 | neurogenin 3 | 0.014 | ||
| KCNJ5 | potassium inwardly-rectifying channel, subfamily J, member 5 | 0.014 | ||
| MBNL2 | muscleblind-like 2 (Drosophila) | 0.014 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.014 | ||
| FOXG1 | forkhead box G1 | 0.014 | ||
| MDC1 | mediator of DNA-damage checkpoint 1 | 0.013 | ||
| CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.013 | Mouse | |
| ESR2 | estrogen receptor 2 (ER beta) | 0.013 | Rat | |
| RBM4 | RNA binding motif protein 4 | 0.013 | ||
| SPRY4 | sprouty homolog 4 (Drosophila) | 0.013 | ||
| NPAS1 | neuronal PAS domain protein 1 | 0.013 | ||
| CTGF | connective tissue growth factor | 0.013 | ||
| IL11 | interleukin 11 | 0.013 | ||
| WNT3 | wingless-type MMTV integration site family, member 3 | 0.013 | Human | |
| DUSP23 | dual specificity phosphatase 23 | 0.013 | ||
| POMC | proopiomelanocortin | 0.013 | ||
| INO80 | INO80 homolog (S. cerevisiae) | 0.012 | ||
| PDE6D | phosphodiesterase 6D, cGMP-specific, rod, delta | 0.012 | ||
| LAMA5 | laminin, alpha 5 | 0.012 | ||
| PTGER3 | prostaglandin E receptor 3 (subtype EP3) | 0.012 | ||
| FZD8 | frizzled homolog 8 (Drosophila) | 0.012 | ||
| SLC9A3R2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 | 0.012 | ||
| GAS1 | growth arrest-specific 1 | 0.012 | ||
| FANCF | Fanconi anemia, complementation group F | 0.012 | ||
| SMC1A | structural maintenance of chromosomes 1A | 0.012 | ||
| TBXA2R | thromboxane A2 receptor | 0.012 | ||
| POU4F3 | POU class 4 homeobox 3 | 0.012 | ||
| TXNDC5 | thioredoxin domain containing 5 (endoplasmic reticulum) | 0.012 | ||
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.012 | ||
| SSBP1 | single-stranded DNA binding protein 1 | 0.012 | ||
| KCTD1 | potassium channel tetramerisation domain containing 1 | 0.012 | ||
| PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.012 | ||
| HMGA1 | high mobility group AT-hook 1 | 0.012 | ||
| ACAN | aggrecan | 0.012 | ||
| ALX3 | ALX homeobox 3 | 0.012 | ||
| BMP7 | bone morphogenetic protein 7 | 0.012 | ||
| WT1 | Wilms tumor 1 | 0.011 | ||
| NBN | nibrin | 0.011 | ||
| WNT10A | wingless-type MMTV integration site family, member 10A | 0.011 | Human | |
| GOLGA2 | golgin A2 | 0.011 | ||
| SOX4 | SRY (sex determining region Y)-box 4 | 0.011 | Human | |
| C1QL1 | complement component 1, q subcomponent-like 1 | 0.011 | ||
| IRX4 | iroquois homeobox 4 | 0.011 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.011 | ||
| SP1 | Sp1 transcription factor | 0.011 | ||
| AMBRA1 | autophagy/beclin-1 regulator 1 | 0.011 | ||
| TG | thyroglobulin | 0.011 | ||
| SHH | sonic hedgehog | 0.011 | ||
| CYP19A1 | cytochrome P450, family 19, subfamily A, polypeptide 1 | 0.011 | ||
| DIO3 | deiodinase, iodothyronine, type III | 0.011 | ||
| PBX1 | pre-B-cell leukemia homeobox 1 | 0.011 | ||
| DLX4 | distal-less homeobox 4 | 0.011 | ||
| LTK | leukocyte receptor tyrosine kinase | 0.011 | ||
| PDGFC | platelet derived growth factor C | 0.011 | ||
| GABPA | GA binding protein transcription factor, alpha subunit 60kDa | 0.011 | ||
| APP | amyloid beta (A4) precursor protein | 0.011 | ||
| SLC18A3 | solute carrier family 18 (vesicular acetylcholine), member 3 | 0.011 | ||
| NPY2R | neuropeptide Y receptor Y2 | 0.011 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.011 | Human Mouse | |
| SIX3 | SIX homeobox 3 | 0.011 | ||
| KLHL24 | kelch-like 24 (Drosophila) | 0.011 | ||
| NEUROG2 | neurogenin 2 | 0.011 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.011 | ||
| PKN2 | protein kinase N2 | 0.011 | ||
| GOLGA4 | golgin A4 | 0.011 | ||
| CTAG2 | cancer/testis antigen 2 | 0.011 | ||
| CFD | complement factor D (adipsin) | 0.011 | ||
| TLX1 | T-cell leukemia homeobox 1 | 0.011 | ||
| CCNG2 | cyclin G2 | 0.011 | ||
| RBBP8 | retinoblastoma binding protein 8 | 0.011 | ||
| COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) | 0.011 | ||
| PDE10A | phosphodiesterase 10A | 0.010 | ||
| PSMD8 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 | 0.010 | ||
| USP42 | ubiquitin specific peptidase 42 | 0.010 | ||
| RUNX2 | runt-related transcription factor 2 | 0.010 | ||
| GOLGB1 | golgin B1 | 0.010 | ||
| TFAP2A | transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | 0.010 | Human | |
| PYY | peptide YY | 0.010 | ||
| ELK1 | ELK1, member of ETS oncogene family | 0.010 | ||
| GAL | galanin prepropeptide | 0.010 | ||
| PTHLH | parathyroid hormone-like hormone | 0.010 | ||
| CYP17A1 | cytochrome P450, family 17, subfamily A, polypeptide 1 | 0.010 | Rat | |
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.010 | ||
| ENTPD2 | ectonucleoside triphosphate diphosphohydrolase 2 | 0.010 | ||
| KIAA1370 | KIAA1370 | 0.010 | ||
| TACR1 | tachykinin receptor 1 | 0.010 | ||
| DHX40 | DEAH (Asp-Glu-Ala-His) box polypeptide 40 | 0.010 | ||
| SIX1 | SIX homeobox 1 | 0.010 | ||
| ACVR1B | activin A receptor, type IB | 0.010 |